Abstract

The CuInSe2/ZnS multiparticulate nanocomposites were first synthesized employing two-step mechanochemical synthesis. In the first step, tetragonal CuInSe2 crystals prepared from copper, indium and selenium precursors were co-milled with zinc acetate dihydrate and sodium sulfide nonahydrate as precursors for ZnS in different molar ratios by mechanochemical route in a planetary mill. In the second step, the prepared CuInSe2/ZnS nanocrystals were further milled in a circulation mill in sodium dodecyl sulphate (SDS) solution (0.5 wt.%) to stabilize the synthesized nanoparticles. The sodium dodecyl sulphate capped CuInSe2/ZnS 5:0-SDS nanosuspension was shown to be stable for 20 weeks, whereas the CuInSe2/ZnS 4:1-SDS one was stable for about 11 weeks. After sodium dodecyl sulphate capping, unimodal particle size distribution was obtained with particle size medians approaching, respectively, 123 nm and 188 nm for CuInSe2/ZnS 5:0-SDS and CuInSe2/ZnS 4:1-SDS nanocomposites. Successful stabilization of the prepared nanosuspensions due to sodium dodecyl sulphate covering the surface of the nanocomposite particles was confirmed by zeta potential measurements. The prepared CuInSe2/ZnS 5:0-SDS and CuInSe2/ZnS 4:1-SDS nanosuspensions possessed anti-myeloma sensitizing potential assessed by significantly reduced viability of multiple myeloma cell lines, with efficient fluorescence inside viable cells and higher cytotoxic efficacy in CuInSe2/ZnS 4:1-SDS nanosuspension.

Highlights

  • We reported the first successful attempt on this objective concerning preparation of CuInSe2 /ZnS nanocrystals with different intercomponent ratio, supplemented by second-step wet stirred media milling route using a circulation mill stabilizing these CuInSe2 /ZnS nanocrystals in 0.5% sodium dodecyl sulphate (SDS) solution

  • The component-variable CuInSe2 /ZnS MNC in a molar CuInSe2 :ZnS ratio approaching 5:0, 4:1 and 1:4 were prepared by co-milling of CuInSe2 and precursors for ZnS preparation, as it was described in more details elsewhere [28,29]

  • It was found that CuInSe2 /ZnS 5:0-SDS nanosuspension was stable for difference can be reasonably explained by deep analysis of the respective par20This weeks, whereas

Read more

Summary

Introduction

Multiparticulate nanocomposites (multinanocomposites (MNC)) represents a group of phase-distinguished nanostructured substances possessing wide application in biomedicine. Stable equi-component CuInSe2 /ZnS colloidal nanocrystals have been prepared employing different nanostructurization technologies as described in more details elsewhere [7,8,13,14]. From technologically-guided and bio-applicability tuning challenges, the most promising approach seems to have highly-stabilized biparticulate CuInSe2 /ZnS MNC with variable ratio between components, like it is achieved in other ZnS-based prototypes [15,16,17]. We reported the first successful attempt on this objective concerning preparation of CuInSe2 /ZnS nanocrystals with different intercomponent ratio, supplemented by second-step wet stirred media milling route using a circulation mill stabilizing these CuInSe2 /ZnS nanocrystals in 0.5% SDS solution

Materials and Methods
Methods
Multiple Myeloma Cell Lines
Nanoparticles Sensitivity by Cell-Based MTT Assay
Nanoparticle Sensitivity by Flow Cytometry Analysis
Observed
Thethat
Biological Activity of SDS of Capped
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call